Urinary Tract Infection (UTI) Treatment Market
Market Insights on Urinary Tract Infection (UTI) Treatment covering sales outlook, demand forecast & up-to-date key trends
Urinary Tract Infection (UTI) Treatment Market By Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides) Indication (Complicated Urinary Tract Infection), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics) & Region - Forecast 2019 - 2029
Urinary Tract Infection (UTI) Treatment Market – Key Research Findings
- Urinary tract infection treatment market size valuated in 2018 was ~US$ 10 Bn.
- The UTI treatment market is anticipated to grow at a CAGR of ~2% over 2019-2029.
- Europe is expected to remain the leading regional market for urinary tract infection treatment.
- Leading companies operating in the UTI treatment market are focusing on expanding production facilities and establishing long-term distribution contracts with major local distribution companies, to stay competitive among their peers in the urinary tract infection market.
- Quinolones, in terms of drug class, are projected to lead the way in urinary tract infection treatment market over the forecast period.
Let us know your requirement to get
100% FREE customization
Top 3 Factors Shaping the Urinary Tract Infection Treatment Market
-
Increasing UTI Prevalence to Drive the Urinary Tract Infection Treatment Market
Urinary tract infection is more common in women compared to men due to their anatomy. Several women experience urinary tract infection more than once in their lifetime. According to certain studies, urinary tract infection affects approximately 150 million people globally. In addition, approximately 11% women visit one physician in a year for urinary tract infection treatment.
Hormonal changes, improper personal hygiene, use of catheters, and other factors are some of the main causes of urinary tract infection. With an increase in the prevalence of urinary tract infection, the urinary tract infection treatment market is expected to witness significant growth in the coming years.
-
Rising Demand for Antibiotics to Contribute to the Demand for Urinary Tract Infection Treatment
Antibiotics are the only treatment options available for urinary tract infection. According to the severity of the infection, a wide range of antibiotics are prescribed. For instance, for uncomplicated urinary tract infection treatment, fluoroquinolones, trimethoprim/sulfamethoxazole, and aminoglycosides are prescribed as initial treatment.
Similarly, for complicated urinary tract infection treatment cases, fluoroquinolones such as ciprofloxacin or ofloxacin are prescribed in case of less severe infection. Apart from these, loss of patent rights of branded drugs and the availability of cost-effective antibiotics from generic companies are among factors that are likely to spur the growth of the urinary tract infection treatment market.
-
Rising Use of Urinary Catheters and Other Drainage Devices Likely to Offer an Uptick to Urinary Tract Infection Treatment Market Growth
The rising incidence of chronic kidney diseases, such as bladder cancer and renal failure, has led to the increase usage of catheters and other drainage devices in patients. Patients using urinary catheters are more likely to acquire complicated UTI. According to World Health Organization (WHO), the risk of bacteriuria is approximately 5% per day for patients using urinary catheters and 40% suffer from nosocomial infections.
Certain factors, such as prolonged duration of catheterisation, not receiving system therapy of antibiotics, bacterial colonisation in drainage bags, rapid fata underlying diseases, and others, are likely to result in catheter-associated urinary tract infection. Hence, increase in the usage of urinary catheters will foster the growth of the urinary tract infection treatment market.
Urinary Tract Infection Treatment Market Structure Analysis
- Key comapnies spearheading the comeptition landscape of the global UTI treatment market, such as Bayer AG, are focused on stregthening their R&D activties for the development of novel drug molecules.
- FMI analyses that a majority of leading players, for instance Allergan Plc, in urinary tract infection treatment market are also prioritizing strategic collaborations and acquisitions to achieve broader availability on market and tap the unmet needs of patients.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystUrinary Tract Infection Treatment: Antibiotics for the Management of Urinary Tract Infection
The Urinary Tract Infection (UTI) treatment market is anticipated to witness growth since antibiotics are the only treatment for the management of the same. Loss of patent rights by branded drugs and the emergence of branded generics and generic drugs are among factors that are likely to boost the urinary tract infection treatment market.
Market Set to Grow by 1.2X between 2019 and 2029
The urinary tract infection treatment market is expected to register considerable growth owing to the rising prevalence of urinary tract infections and increase in the number of hospital visits for urinary tract infection testing as well as treatment. Moreover, the high demand for antibiotics in urinary tract infection treatment and growth in the number of generic players is likely to propel the growth of the urinary tract infection treatment market.
Emerging Countries Foster New Growth Opportunities for the Urinary Tract Infection Treatment Market
Europe holds a prominent revenue share among other regions in the global urinary tract infection treatment market in 2019. However, developing countries, such as China, India, and South Korea, have witnessed growth in the urinary tract infection treatment market due to increasing awareness about urinary tract infection treatment and rising government initiatives for healthcare spending.
The Broader Perspective
Various manufacturers are engaged in strategic acquisitions and collaborations with different companies and distribution channels to increase the sales of their products and enhance their business operations.
How Growth will Unfold
The prevalence of UTI is increasing at an alarming rate. Improper use of disposable hygiene products for personal use, administration of catheters in urethra, sexual activity, menopause, and certain other factors are anticipated to boost the urinary tract infection treatment market. The growing demand for antibiotics and the low cost of generic drugs is also expected to spur the growth of the urinary tract infection treatment market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
UTI (URINARY TRACT INFECTION) TREATMENT MARKET TAXONOMY
The global urinary tract infection treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Drug Class
- Penicillin & Combinations
- Quinolones
- Cephalosporin
- Aminoglycoside Antibiotics
- Sulphonamides (Sulfamethoxazole, Trimethoprim)
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nitrofurans (Nitrofurantoin)
- Others
By Indication
- Complicated Urinary Tract Infection
- Uncomplicated Urinary Tract Infection
By Distribution Channel
- Hospital Pharmacies
- Gynecology and Urology Clinics
- Drug Stores
- Retail Pharmacies
- Online Drug Stores
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
The urinary tract infections market is predicted to grow at 2% CAGR through 2032.
Asia Pacific urinary tract infections market holds the highest revenue potential.
The urinary tract infections market is expected to surpass US$ 10.29 Bn by 2032.
The urinary tract infections market size is anticipated to be over US$ 12.54 Bn in 2022.
Table of Content
1. Executive Summary
2. Market Overview
3. Key Market Trends
4. Key Success Factors
5. Global Urinary Tract Infection Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Favourable Incentive & Reimbursement Policies
6.1.2. Increasing Consumption of Antibiotics per Capita
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increase in Drug Resistance
6.2.2. Patent Loss of Branded Drugs
6.2.3. Government Regulations in Product Approval
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2014 - 2018
7.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Drug Class, 2019 - 2029
7.3.1. Penicillin and Combinations
7.3.1.1. Amoxicillin
7.3.1.2. Amoxicillin and Clavulanate Potassium
7.3.1.3. Others
7.3.2. Quinolones
7.3.2.1. Ciprofloxaxin
7.3.2.2. Levofloxaxin
7.3.2.3. Nalidixic acid
7.3.2.4. Norfloxacin
7.3.2.5. Others
7.3.3. Cephalosporin
7.3.3.1. Ceftriaxone
7.3.3.2. Cefuroxime
7.3.3.3. Cefixime
7.3.3.4. Cephalexin
7.3.4. Aminoglycoside Antibiotics
7.3.4.1. Amikacin
7.3.4.2. Gentamicin
7.3.5. Sulphonamides (Sulfamethoxazole +Trimethoprim)
7.3.6. Azoles and Amphotericin B
7.3.7. Tetracycline (Doxycycline)
7.3.8. Nirtofurans (Nitrofurantoin)
7.3.9. Other
7.4. Market Attractiveness Analysis By Drug Class
8. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Indication
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Analysis By Indication, 2014 - 2018
8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Indication, 2019- 2029
8.3.1. Complicated Urinary Tract Infection
8.3.2. Uncomplicated Urinary Tract Infection
8.4. Market Attractiveness Analysis By Indication
9. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Analysis By Distribution Channel, 2014 - 2018
9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Distribution Channel, 2019 - 2029
9.3.1. Hospital Pharmacies
9.3.2. Gynaecology and Urology Clinics
9.3.3. Drug Stores
9.3.4. Retail Pharmacies
9.3.5. Online Drug Stores
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Analysis By Region, 2014 - 2018
10.3. Current Market Size (US$ Mn) and Analysis and Forecast By Region, 2019 - 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug Class
11.3.3. By Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug Class
11.4.3. By Indication
11.4.4. By Distribution Channel
11.5. Drivers and Restraints - Impact Analysis
12. Latin America Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Drug Class
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug Class
12.4.3. By Indication
12.4.4. By Distribution Channel
12.5. Drivers and Restraints - Impact Analysis
13. Europe Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Drug Class
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug Class
13.4.3. By Indication
13.4.4. By Distribution Channel
13.5. Drivers and Restraints - Impact Analysis
14. South Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Drug Class
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug Class
14.4.3. By Indication
14.4.4. By Distribution Channel
14.5. Drivers and Restraints - Impact Analysis
15. East Asia Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug Class
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Class
15.4.3. By Indication
15.4.4. By Distribution Channel
15.5. Drivers and Restraints - Impact Analysis
16. Oceania Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug Class
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug Class
16.4.3. By Indication
16.4.4. By Distribution Channel
16.5. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Urinary Tract Infection Treatment Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
17.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. Turkey
17.4.1.3. Northern Africa
17.4.1.4. South Africa
17.4.1.5. Rest of Middle East and Africa
17.4.2. By Drug Class
17.4.3. By Indication
17.4.4. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Drug Class
17.5.3. By Indication
17.5.4. By Distribution Channel
17.6. Drivers and Restraints - Impact Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Deep Dive
18.2.1. Bayer AG
18.2.1.1. Overview
18.2.1.2. Key Financials
18.2.1.3. Profitability by Market Segments (Product/Channel/Region)
18.2.1.4. Key Development
18.2.1.5. SWOT Analysis
18.2.1.6. Strategy Overview
18.2.1.6.1. Marketing Strategy
18.2.1.6.2. Product Strategy
18.2.1.6.3. Channel Strategy
18.2.2. GlaxoSmithKline Pharmaceuticals Ltd.
18.2.2.1. Overview
18.2.2.2. Key Financials
18.2.2.3. Profitability by Market Segments (Product/Channel/Region)
18.2.2.4. Key Development
18.2.2.5. SWOT Analysis
18.2.2.6. Strategy Overview
18.2.2.6.1. Marketing Strategy
18.2.2.6.2. Product Strategy
18.2.2.6.3. Channel Strategy
18.2.3. Pfizer
18.2.3.1. Overview
18.2.3.2. Key Financials
18.2.3.3. Profitability by Market Segments (Product/Channel/Region)
18.2.3.4. Key Development
18.2.3.5. SWOT Analysis
18.2.3.6. Strategy Overview
18.2.3.6.1. Marketing Strategy
18.2.3.6.2. Product Strategy
18.2.3.6.3. Channel Strategy
18.2.4. Allergan Plc
18.2.4.1. Overview
18.2.4.2. Key Financials
18.2.4.3. Profitability by Market Segments (Product/Channel/Region)
18.2.4.4. Key Development
18.2.4.5. SWOT Analysis
18.2.4.6. Strategy Overview
18.2.4.6.1. Marketing Strategy
18.2.4.6.2. Product Strategy
18.2.4.6.3. Channel Strategy
18.2.5. Almirall SA
18.2.5.1. Overview
18.2.5.2. Key Financials
18.2.5.3. Profitability by Market Segments (Product/Channel/Region)
18.2.5.4. Key Development
18.2.5.5. SWOT Analysis
18.2.5.6. Strategy Overview
18.2.5.6.1. Marketing Strategy
18.2.5.6.2. Product Strategy
18.2.5.6.3. Channel Strategy
18.2.6. Bristol-Myers Squibb
18.2.6.1. Overview
18.2.6.2. Key Financials
18.2.6.3. Profitability by Market Segments (Product/Channel/Region)
18.2.6.4. Key Development
18.2.6.5. SWOT Analysis
18.2.6.6. Strategy Overview
18.2.6.6.1. Marketing Strategy
18.2.6.6.2. Product Strategy
18.2.6.6.3. Channel Strategy
18.2.7. Merck & Co., Inc.
18.2.7.1. Overview
18.2.7.2. Key Financials
18.2.7.3. Profitability by Market Segments (Product/Channel/Region)
18.2.7.4. Key Development
18.2.7.5. SWOT Analysis
18.2.7.6. Strategy Overview
18.2.7.6.1. Marketing Strategy
18.2.7.6.2. Product Strategy
18.2.7.6.3. Channel Strategy
19. Assumptions and Acronyms Used
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 03: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 04: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 05: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 06: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 07: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 08: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 09: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 10: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 11: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 12: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 13: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 15: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 16: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 17: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 18: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 19: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 20: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 21: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 22: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 23: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 24: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 25: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 26: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 27: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 28: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 29: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 30: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 31: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 32: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 33: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 34: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 35: China Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 36: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 37: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 38: India Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 39: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 40: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 41: South Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 03: Global Urinary Tract Infection Treatment Market Absolute $ Opportunity, 2019–2029
Figure 04: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 05: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Drug Class, 2019 – 2029
Figure 06: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 07: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 08: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Indication, 2019 – 2029
Figure 09: Global Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 10: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 11: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2019 – 2029
Figure 12: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel –2019 & 2029
Figure 13: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029
Figure 14: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Region, 2019 – 2029
Figure 15: Global Urinary Tract Infection Treatment Market Analysis by Region–2019 & 2029
Figure 16: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 17: North America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 18: North America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 19: North America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 20: North America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 21: North America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 22: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 23: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 24: Latin America Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 25: Latin America Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 26: Latin America Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 27: Latin America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 28: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 29: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 30: Europe Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 31: Europe Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 32: Europe Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 33: Europe Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 34: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 35: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 36: South Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 37: South Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 38: South Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 39: South Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 40: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 41: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 42: East Asia Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 43: East Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 44: East Asia Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 45: East Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 46: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 47: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 48: Oceania Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 49: Oceania Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 50: Oceania Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 51: Oceania Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 52: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2014–2018
Figure 53: Middle East and Africa Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 54: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Country–2019 & 2029
Figure 55: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 56: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 57: Middle East and Africa Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 58: Emerging Countries Market Value Share (2019)
Figure 59: Emerging Countries Urinary Tract Infection Treatment Market Value (US$ Mn), By Key Countries, 2019-2029
Figure 60: China Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 61: China Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 62: China Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 63: India Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 64: India Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 65: India Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Figure 66: South Africa Urinary Tract Infection Treatment Market Analysis by Drug Class–2019 & 2029
Figure 67: South Africa Urinary Tract Infection Treatment Market Analysis by Indication–2019 & 2029
Figure 68: South Africa Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2019 & 2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
